HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Joseph B Margolick Selected Research

Highly Active Antiretroviral Therapy (HAART)

10/2015Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study.
2/2015The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation.
1/2014Sleep disordered breathing, fatigue, and sleepiness in HIV-infected and -uninfected men.
1/2014Association between systemic inflammation and obstructive sleep apnea in men with or at risk for HIV infection.
1/2014Cochlear function among HIV-seropositive and HIV-seronegative men and women.
1/2013The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts.
3/2012Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.
1/2012Prevalence of abnormalities in vestibular function and balance among HIV-seropositive and HIV-seronegative women and men.
9/2011A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men.
8/2011CD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Joseph B Margolick Research Topics

Disease

35Acquired Immunodeficiency Syndrome (AIDS)
10/2015 - 04/2002
33Infection
11/2015 - 01/2002
21HIV Infections (HIV Infection)
10/2015 - 01/2003
8Viremia
03/2012 - 04/2003
7Neoplasms (Cancer)
02/2015 - 10/2007
6Disease Progression
10/2012 - 01/2002
4Kaposi Sarcoma (Kaposi's Sarcoma)
12/2010 - 04/2002
3Inflammation
10/2015 - 01/2014
3Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2010 - 04/2002
2Cardiovascular Diseases (Cardiovascular Disease)
12/2015 - 03/2014
2Coronary Stenosis (Coronary Artery Stenosis)
12/2015 - 03/2014
2Coronary Artery Disease (Coronary Atherosclerosis)
12/2015 - 03/2014
2Atherosclerosis
04/2015 - 03/2014
2Necrosis
02/2015 - 01/2014
2Autoimmune Diseases (Autoimmune Disease)
01/2012 - 11/2003
2Anus Neoplasms (Anal Cancer)
12/2010 - 08/2008
2Breast Neoplasms (Breast Cancer)
05/2009 - 10/2008
1Oropharyngeal Neoplasms
02/2015
1Hypogonadism (Hypergonadotropic Hypogonadism)
01/2015
1Heart Diseases (Heart Disease)
06/2014
1Pathologic Constriction (Stenosis)
03/2014
1Myocardial Infarction
03/2014
1Fatigue
01/2014
1Obstructive Lung Diseases (Obstructive Lung Disease)
01/2014
1Sleep Apnea Syndromes (Sleep Apnea)
01/2014
1Chronic Obstructive Pulmonary Disease (COPD)
01/2013
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2013
1Multiple Sclerosis
01/2013
1Lung Diseases (Lung Disease)
01/2013
1Colitis
08/2012
1Disease Susceptibility (Diathesis)
08/2012
1Progressive Multifocal Leukoencephalopathy
10/2011
1Hepatitis B
08/2011
1Liver Diseases (Liver Disease)
01/2011
1Lymphoma (Lymphomas)
04/2010
1Vascular Neoplasms (Neoplasms, Vascular)
02/2010
1Leukemia
10/2008

Drug/Important Bio-Agent (IBA)

11RNA (Ribonucleic Acid)IBA
03/2015 - 01/2002
5AntigensIBA
05/2014 - 05/2003
4DNA (Deoxyribonucleic Acid)IBA
11/2015 - 06/2014
4Biological Markers (Surrogate Marker)IBA
02/2015 - 04/2002
4Immunoglobulin G (IgG)IBA
02/2015 - 10/2011
4AntibodiesIBA
02/2015 - 01/2010
4Hemoglobins (Hemoglobin)IBA
09/2011 - 01/2003
3Carbon MonoxideIBA
01/2014 - 09/2008
3EpitopesIBA
01/2014 - 12/2009
3AmphetaminesIBA
07/2009 - 04/2008
2CalciumIBA
12/2015 - 03/2014
2Iohexol (Omnipaque)FDA Link
10/2015 - 01/2014
2InterleukinsIBA
02/2015 - 01/2014
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2015 - 06/2014
2PeptidesIBA
03/2014 - 01/2010
2Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
01/2013 - 01/2012
2HLA-B57IBA
10/2012 - 09/2010
2Interleukin-10 (Interleukin 10)IBA
08/2012 - 04/2010
2Interferon-gamma (Interferon, gamma)IBA
02/2010 - 10/2002
2Paclitaxel (Taxol)FDA LinkGeneric
05/2009 - 10/2008
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2009 - 03/2004
2Protease Inhibitors (Protease Inhibitor)IBA
03/2009 - 03/2004
2Cocaine (Cocaine HCl)IBA
02/2009 - 04/2008
2Reverse Transcriptase InhibitorsIBA
04/2008 - 09/2005
2Glucose (Dextrose)FDA LinkGeneric
09/2005 - 05/2005
1OsteoprotegerinIBA
12/2015
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
04/2015
1Cytokine Receptor gp130IBA
02/2015
1C-Reactive ProteinIBA
02/2015
1Oncogene Proteins (Oncogene Protein)IBA
02/2015
1Proteins (Proteins, Gene)IBA
02/2015
1Phosphotransferases (Kinase)IBA
01/2015
1Testosterone (Sustanon)FDA Link
01/2015
1CyclinsIBA
01/2015
1Interleukin-6 (Interleukin 6)IBA
06/2014
1AdiponectinIBA
03/2014
1AdipokinesIBA
03/2014
1Histone Deacetylases (Histone Deacetylase)IBA
01/2014
1Histone Deacetylase InhibitorsIBA
01/2014
1Viral DNAIBA
12/2011
1Immunoglobulin M (IgM)IBA
12/2011
1Neutralizing AntibodiesIBA
01/2011
1insulin receptor-related receptor (IRR)IBA
12/2010
1Interleukin-13IBA
04/2010
1Interleukin-4 (Interleukin 4)IBA
04/2010
1HIV AntibodiesIBA
01/2010
1HLA-B Antigens (HLA-B)IBA
12/2009
1Amphetamine (Amfetamine)FDA LinkGeneric
07/2009
1Oxyquinoline (8 Hydroxyquinoline)FDA Link
05/2009
1Street Drugs (Illicit Drugs)IBA
02/2009
1Interleukin-12 (IL 12)IBA
12/2008
1prolinedithiocarbamate (PDTC)IBA
10/2008
1NF-kappa B (NF-kB)IBA
10/2008
1Chemokine CCL5IBA
07/2008
1Chemokine CXCL12IBA
07/2008

Therapy/Procedure

33Highly Active Antiretroviral Therapy (HAART)
10/2015 - 04/2002
2Art Therapy
01/2011 - 09/2005
1Immunotherapy
01/2014
1Aftercare (After-Treatment)
01/2011
1Withholding Treatment
01/2011
1Therapeutics
11/2009
1Drug Therapy (Chemotherapy)
05/2009
1Heterologous Transplantation (Xenotransplantation)
10/2008